Far from it.
Look at all the past independent studies. RAC is doing the right thing and doing more recent ones to put any questions the FDA might have to rest.
As Dr T said in the AGM (I think), Pharma want more data before they decide to partner. So data is what the team is establishing through more tailored and detailed studies. The next 12 months will be exciting.
RACE- New website feedback, page-23
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9998 | $1.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |